IGF-1 support More GH means more downstream IGF-1
Semaglutide can cause the following side effects: headaches, dizziness, nausea, vomiting, stomach pain, fatigue, upset stomach, constipation, and diarrhea, as well as belching and heartburn
Four-point analytical testing Each lot is analysed by HPLC for purity, mass spectrometry for amino acid identity, and LAL testing for endotoxins, with independent third-party verification on top of in-house quality control
Semaglutide was a major focus of Trilliant Health's 2023 "Trends Shaping the Health Economy." The report reveals that sales of semaglutide (including Ozempic and Wegovy) totaled $10.7B in 2021
Semaglutide can help with weight management and glycemic control when used frequently in conjunction with the right lifestyle changes, such as eating a nutritious diet and getting regular exercise
A 2.5 mg target dose is 2,500 mcg